⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CPHI News
China Pharma Holdings, Inc.
Form 8-K
sec.gov
CPHI
Santhera Licenses AGAMREE® (Vamorolone) to Nxera Pharma in Japan, South Korea, Australia and New Zealand in a Deal Valued at up to USD 205 Million Plus Royalties
globenewswire.com
CPHI
CardioPharma Requests Applications to Investigate the Non-Cardiovascular Benefits of CVD Polypills
prnewswire.com
CPHI